A/s Novo, 10% Owner at Corvus Pharmaceuticals, Inc. (CRVS), bought 1,023,554 shares at $15.00 ($10.0M) on 2016-03-29, disclosed to the SEC on 2016-03-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 356,888 | $0 | 0.0% |
| 2 | $15.00 | 666,666 | $10.0M | 100.0% |
| Total | $9.77 avg | 1,023,554 | $10.0M | 100% |
| Filing → |
| RETA | SELL | 2017-06-12 | $5.7M | — | Filing → |
| RETA | SELL | 2017-06-07 | $2.5M | — | Filing → |
| APEN | SELL | 2017-05-11 | $590K | — | Filing → |